(0)

Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Washington Marriott Wardman Park

Feb 27, 2014 7:00 AM - Feb 28, 2014 4:30 PM

2660 Woodley Road, NW, , Washington, DC 20008 , USA

Marketing Pharmaceuticals 2014: Regulating Drug Marketing in the Ever-Changing Regulatory/Legal/Health Care Environment

Back to Agenda

Session 7 Breakout 1 - Substantial Evidence

Session Chair(s)

Kristina Vlaovic, MPH

Kristina Vlaovic, MPH

Vice President, Regulatory, Safety and Pharmacovigilance

HALOZYME Inc., United States

Substantial evidence serves as the cornerstone of promotional claims. This interactive session will provide an overview of the considerations which companies must take into account when developing promotional claims, and breakout groups for participants to evaluate and discuss several relevant scenarios with peers and a group of industry experts.

Speaker(s)

Sue E. Duvall, MBA, MPA, RN

Panelist

Sue E. Duvall, MBA, MPA, RN

GoProMo LLC, United States

Lynette Hopkinson

Panelist

Lynette Hopkinson

Vertex Pharmaceuticals Incorporated, United States

Vice President, Commercial Regulatory Affairs, Global Regulatory Affairs

Leah Palmer, PharmD

Panelist

Leah Palmer, PharmD

United States

Consultant, Regulatory Promotion

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.